Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of VEAB Ventilation Entreprenad
Mandate

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of VEAB Ventilation Entreprenad

June 28, 2021 Employment and Benefits M&A Real Estate and Construction Banking and Finance

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ventilation Entreprenad VEAB, Veab Ventilation Entreprenad i Kristianstad, VEAB Ventilation Entreprenad I Helsingborg, Styr Entreprenad i Malmö and Energi & Klimatteknik i Tygelsjö.

The companies provide contracting services related to ventilation as well as service on real estate technical installations, and are based in Skåne. Together, the companies have a turnover of approximately SEK 370 million. The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of partner Christina Kokko together with Karl Klackenberg, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Construction), Elin Broman (Employment), Karl-Gustaw Tobola (Financing) and Frida Ställborn (Real Estate).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025